Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis
Table 1
Demographic data and comorbidities of 141 subjects enrolled in this study.
Characteristics
Group A ()
Group B ()
Group C ()
Male/female
17/12
15/21
36/40
Mean age (y)
65 ()
68 ()
66 ()
Duration of hospitalization
14 ()
15 ()
11 ()
Smoking
9 (31.0%)
12 (33.3%)
25 (32.9%)
Alcohol consumption
10 (34.5%)
12 (33.3%)
25 (32.9%)
Type 2 diabetes mellitus
4 (13.8%)
6 (16.6%)
45 (59.2%)
Essential hypertension
13 (44.8%)
15 (41.7%)
31 (40.8%)
Microbiology
Gram-negative organisms
Escherichia coli
11 (37.9%)
15 (41.6%)
—
Klebsiella spp.
3 (10.4%)
4 (11.1%)
—
Pseudomonas spp.
4 (13.8%)
3 (8.3%)
—
Enterobacter spp.
2 (6.9%)
3 (8.3%)
—
Acinetobacter spp.
1 (3.4%)
1 (2.8%)
—
Others
1 (3.4%)
1 (2.8%)
—
Gram-positive organisms
Enterococcus spp.
5 (17.3%)
6 (16.7%)
—
Streptococcus spp.
2 (6.9%)
1 (2.8%)
—
Staphylococcus spp.
0 (0.0%)
1 (2.8%)
—
Others
0 (0.0%)
1 (2.8%)
—
Group A: AC patients with sepsis; Group B: AC patients without sepsis; Group C: individuals without AC or other infections. The microbiology results of culture in Group A were from blood and bile; the microbiology results of culture in Group B were from bile.
